Last reviewed · How we verify

NCT06048055

Effect of Transcutaneous Vagus Nerve Stimulation on Upper Limb Function in Stroke Patients

Completed NA Last updated 30 April 2025
What this trial tests

NA trial testing Transcutaneous auricular vagus nerve stimulation in Stroke, Ischemic in 40 participants. Completed in 10 April 2024.

Timeline
1 October 2023
Primary endpoint
3 April 2024
10 April 2024

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment40
Start date1 October 2023
Primary completion3 April 2024
Estimated completion10 April 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 45 to 65, any sex, with Stroke, Ischemic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this interventional study is to investigate the therapeutic efficacy of non-invasive vagus nerve stimulation on upper limb function in chronic stroke patients . The main question is: •Is there a significant effect of non-invasive vagal nerve stimulation on upper limb motor function in stroke patients? Participants will be assigned into two groups. They will receive 12 sessions of true or sham transcutaneous auricular vagus nerve stimulation for 30 minutes immediately followed by 30 minutes of selected physical therapy program, three sessions per week for four weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Transcutaneous auricular vagus nerve stimulation

Trials testing the same drug.

Other recruiting trials for Stroke, Ischemic

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06048055.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing